RxDoctor Payments DataLook up a doctor →

Mazen Nashed, MD

Cardiovascular Disease · Bridgeport, WVNPI 1124114574

Payments from drug & device makers

$14,277in general payments, 2019–2025

Across 815 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$2K
  • Teva Pharmaceuticals USA, Inc.$1K
  • Novo Nordisk$1K
  • Jazz Pharmaceuticals Inc.$877
  • MDD US Operations, LLC$574
  • plus $7K from 44 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)78$1,561
AbbVie(2 entities)92$1,516
Teva Pharmaceuticals USA, Inc.87$1,224
Novo Nordisk80$1,111
Jazz Pharmaceuticals Inc.76$877
MDD US Operations, LLC9$574
Novartis33$565
Amgen24$525
Lundbeck LLC24$510
Biogen26$492
Lilly USA, LLC28$485
Sunovion Pharmaceuticals Inc.26$462
Argenx US, Inc.14$370
Greenwich Biosciences, Inc.20$323
Kyowa Kirin, Inc.15$303
Neurocrine Biosciences, Inc.16$303
Neurelis, Inc.14$300
Supernus Pharmaceuticals, Inc.35$280
Avanir Pharmaceuticals, Inc.10$206
Acadia Pharmaceuticals Inc8$175
Biohaven Pharmaceuticals, Inc.3$174
Amneal Pharmaceuticals LLC9$165
Axsome Therapeutics, Inc.6$155
UCB, Inc.6$151
Harmony Biosciences LLC10$145
SK Life Science, Inc.5$133
Pfizer6$122
Scilex Pharmaceuticals Inc.6$121
Biohaven Pharmaceutical Holding Company Ltd.5$107
Eisai Inc.4$92
Tanabe Pharma America, Inc.4$79
EMD Serono, Inc.4$73
Arbor Pharmaceuticals, Inc.3$55
Vanda Pharmaceuticals Inc.2$50
Exact Sciences2$49
Mylan Specialty L.p.2$47
Currax Pharmaceuticals LLC3$47
Bayer3$44
Portola Pharmaceuticals, LLC2$38
E.r. Squibb & Sons, L.L.C.2$37
Amarin Pharma, Inc.2$37
Impel Pharmaceuticals Inc.2$34
Akcea Therapeutics, Inc.1$28
Merck2$27
Genentech USA, Inc.1$22
Aquestive Therapeutics, Inc.1$21
Banner Life Sciences, LLC1$17
Esperion Therapeutics, Inc.1$16
Upsher-smith Laboratories LLC1$15
Abbott1$12

How this compares

$14,277 in reported general payments places this provider in the 80th percentile of 100 cardiovascular disease providers in West Virginia.

See all cardiovascular disease providers in West Virginia →

Medicare billing

Part B allowed, 2024
$85,615
Medicare patients
95
Services billed
1,547

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Bridgeport

See the full list for West Virginia →

Where these figures come from

Is this you, or does something look wrong? →